1st Faculty of Medicine Charles University 1st Faculty of Medicine Charles University BIOCEV
lvysa 15.02.2018

Petrák Lab

Publications (dedicated to NPU=N or Biocev=B, international collaboration=I, collaboration with hospital=H, from group in Inst.131/from Detached group)

2017

Zimmermannova O, Doktorova E, Stuchly J, Kanderova V, Kuzilkova D, Strnad H, Starkova J, Alberich-Jorda M, Falkenburg JHF, Trka J, Petrak J, Zuna J, Zaliova M. An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia. Oncogene. 2017 Oct 26;36(43):5985-5994. doi: 10.1038/onc.2017.210. (IF 7.519) [PDF] (B, N, H, I, 131)

Vyoral D, Jiri Petrak. Therapeutic potential of hepcidin - the master regulator of iron metabolism. Pharmacol Res. 2017 Jan;115:242-254. doi: 10.1016/j.phrs.2016.11.010. Review. PubMed PMID: 27867027. (IF 4.480) (B, N, 131)

Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, Pluhacek T, Spatenka J, Kovalcikova J, Drahota Z, Kautzner J, Pirk J, Houstek J. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail. 2017 Apr;19(4):522-530. doi: 10.1002/ejhf.640. (IF 6.968) [PDF] (B, N, I, H, 131)

Vit O, Petrak J. Integral membrane proteins in proteomics. How to break open the black box? J Proteomics. 2017 Feb 5. pii: S1874-3919(16)30361-X. doi: 10.1016/j.jprot.2016.08.006. (IF 3.914) [PDF] (B, 131)

2016

Sedmera D, Neckar J, Benes J Jr, Pospisilova J, Petrak J, Sedlacek K, Melenovsky V. Changes in Myocardial Composition and Conduction Properties in Rat Heart Failure Model Induced by Chronic Volume Overload. Front Physiol. 2016 Aug 25;7:367. doi: 10.3389/fphys.2016.00367. (IF 4.031) [PDF] (B, H, 131)

Large-scale identification of membrane proteins based on analysis of trypsin-protected transmembrane segments. O. Vit, A. Kadek, J. Hausner, J. Sklenar, K. Harant, P. Novak, M. Scigelova, G. Woffendin and J. Petrák. J Proteomics. 2016 Mar 11. pii: S1874-3919(16)30069-0. (IF 3.880) [PDF] (B, I, 131)

Toman O, Kabickova T, ViT O, Fiser R, Machova Polakova K, Zach J, Linhartova J, Vyoral D and Petrak J. Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target. Oncology Reports, 2016 (in print) (IF 2.48) [PDF] (B, H, 131)